The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia

Publisher： Karger

E-ISSN： 1660-2862|13|2-3|154-156

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.13, Iss.2-3, 2013-09, pp. : 154-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 222-224

Karger

Access to resources Recommend Favorite

α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models

By  

Neurodegenerative Diseases, Vol. 14, Iss. 1, 2013-09 ,pp. : 1-17

Karger

Access to resources Recommend Favorite

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease

By Yasuda Toru  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1312-1321

Springer Publishing Company

Access to resources Recommend Favorite

Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2011-12 ,pp. : 64-72

Karger

Access to resources Recommend Favorite

Delay Discounting of Reward and Caudate Nucleus Volume in Individuals with α-Synuclein Gene Duplication before and after the Development of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 11, Iss. 2, 2012-10 ,pp. : 72-78

Karger

Access to resources Recommend Favorite